Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Capital Expenditures: 2021-2024

Historic Capital Expenditures for biote (BTMD) over the last 4 years, with FY2024 value amounting to $6.4 million.

  • biote's Capital Expenditures fell 6780.65% to $499000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 190.34%. This contributed to the annual value of $6.4 million for FY2024, which is 17315.21% up from last year.
  • Per biote's latest filing, its Capital Expenditures stood at $6.4 million for FY2024, which was up 17315.21% from $2.4 million recorded in FY2023.
  • Over the past 5 years, biote's Capital Expenditures peaked at $6.4 million during FY2024, and registered a low of $1.5 million during FY2022.
  • Over the past 4 years, biote's median Capital Expenditures value was $2.4 million (recorded in 2021), while the average stood at $3.2 million.
  • Per our database at Business Quant, biote's Capital Expenditures tumbled by 3620.18% in 2022 and then surged by 17315.21% in 2024.
  • biote's Capital Expenditures (Annual) stood at $2.4 million in 2021, then crashed by 36.2% to $1.5 million in 2022, then surged by 56.41% to $2.4 million in 2023, then soared by 173.15% to $6.4 million in 2024.
  • Its last three reported values are $6.4 million in FY2024, $2.4 million for FY2023, and $1.5 million during FY2022.